SG11201601798RA - A method to direct differentiation of pluripotent stem cells into functional heart muscle - Google Patents

A method to direct differentiation of pluripotent stem cells into functional heart muscle

Info

Publication number
SG11201601798RA
SG11201601798RA SG11201601798RA SG11201601798RA SG11201601798RA SG 11201601798R A SG11201601798R A SG 11201601798RA SG 11201601798R A SG11201601798R A SG 11201601798RA SG 11201601798R A SG11201601798R A SG 11201601798RA SG 11201601798R A SG11201601798R A SG 11201601798RA
Authority
SG
Singapore
Prior art keywords
stem cells
pluripotent stem
heart muscle
direct differentiation
functional heart
Prior art date
Application number
SG11201601798RA
Inventor
Wolfram-Hubertus Zimmermann
James Hudson
Malte Tiburcy
Original Assignee
Repairon Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repairon Gmbh filed Critical Repairon Gmbh
Publication of SG11201601798RA publication Critical patent/SG11201601798RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657Cardiomyocytes; Heart cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/155Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/16Activin; Inhibin; Mullerian inhibiting substance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • C12N2501/415Wnt; Frizzeled
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/72Transferases [EC 2.]
    • C12N2501/727Kinases (EC 2.7.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
SG11201601798RA 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle SG11201601798RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13185344 2013-09-20
PCT/EP2014/069951 WO2015040142A1 (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle

Publications (1)

Publication Number Publication Date
SG11201601798RA true SG11201601798RA (en) 2016-04-28

Family

ID=49261445

Family Applications (3)

Application Number Title Priority Date Filing Date
SG11201601798RA SG11201601798RA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle
SG10201910753RA SG10201910753RA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle
SG10201802167TA SG10201802167TA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG10201910753RA SG10201910753RA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle
SG10201802167TA SG10201802167TA (en) 2013-09-20 2014-09-19 A method to direct differentiation of pluripotent stem cells into functional heart muscle

Country Status (10)

Country Link
US (3) US10329532B2 (en)
EP (2) EP3575393A1 (en)
JP (2) JP6681825B2 (en)
CN (2) CN112175900A (en)
AU (1) AU2014323098B2 (en)
CA (1) CA2924816C (en)
DK (1) DK3047019T3 (en)
ES (1) ES2741806T3 (en)
SG (3) SG11201601798RA (en)
WO (1) WO2015040142A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10597633B2 (en) 2014-05-16 2020-03-24 Koninklijke Nederlandse Akademie Van Wetenschappen Culture method for organoids
HUE057135T2 (en) 2015-09-01 2022-04-28 Ncardia B V An in vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population
KR101781693B1 (en) 2015-09-24 2017-09-26 서울대학교병원 Process for differentiation of cardiovascular cells from induced pluripotent stem cells prepared by human circulation multipotent adult stem cells(CiMS) and uses thereof
GB201603569D0 (en) * 2016-03-01 2016-04-13 Koninklijke Nederlandse Akademie Van Wetenschappen Improved differentiation method
WO2017156762A1 (en) * 2016-03-18 2017-09-21 Institute Of Biophysics, Chinese Academy Of Sciences A cell culture medium and culture medium supplement
CN106244526B (en) * 2016-08-23 2020-09-11 北京赛贝生物技术有限公司 Myocardial differentiation kit and culture method of myocardial cells
CN106244527B (en) * 2016-08-29 2019-10-08 广东依浦赛生物科技有限公司 Source of people iPS stem cell in vitro directed differentiation is the kit and method of cardiac muscle cell
CA3045182A1 (en) * 2016-12-04 2018-06-07 University Health Network Generating atrial and ventricular cardiomyocyte lineages from human pluripotent stem cells
GB201621594D0 (en) * 2016-12-19 2017-02-01 Univ Leuven Kath Novel cell based methods for healing of bone, cartilage and joint disorders
WO2018139548A1 (en) * 2017-01-26 2018-08-02 国立大学法人大阪大学 Medium for inducing differentiation of stem cells into mesodermal cells and method for producing mesodermal cells
CN106867961A (en) * 2017-03-27 2017-06-20 广州润虹医药科技有限公司 A kind of induced multi-potent stem cell forms mesoblastemic inducing culture and abductive approach
WO2019126315A1 (en) * 2017-12-19 2019-06-27 The Regents Of The University Of Michigan Cardiac microtissue and uses thereof
CN108456654A (en) * 2018-02-22 2018-08-28 上海产业技术研究院 Serum free culture system for promoting source of human stem cell cardiac muscle cell maturation
EP3540046A1 (en) * 2018-03-13 2019-09-18 Medizinische Hochschule Hannover Process for producing cardiac organoids
US20210284965A1 (en) * 2018-07-13 2021-09-16 Lothar Germeroth Non-immunogenic engineered tissue and methods of producing and using the same
CN111214703B (en) * 2018-11-25 2021-06-15 中国科学院大连化学物理研究所 iPS-derived myocardial cell composite patch and preparation and application thereof
CN109619087A (en) * 2018-11-27 2019-04-16 山东奥博森生物药业股份有限公司 A kind of small intestinal mucosa stem cell cryopreserving liquid and cryopreservation methods
EP3927814A1 (en) 2019-02-21 2021-12-29 Stembiosys, Inc. Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ecm, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds
WO2020171345A1 (en) * 2019-02-21 2020-08-27 고려대학교 산학협력단 METHOD FOR DIFFERENTIATION OF STEM CELL INTO MATURE CARDIOMYOCYTE ACCORDING TO TYPE BY USING TGFβ1
CN109749986B (en) * 2019-03-13 2021-04-02 武汉大学 Method for obtaining pancreatic precursor cells and pancreatic beta cells by differentiation of human pluripotent stem cells
KR20220035429A (en) * 2019-07-12 2022-03-22 게놈 바이오로직스 유쥐 Methods for generating cardiac tissue mimetics
CN110511904B (en) * 2019-08-21 2021-03-19 云南中科灵长类生物医学重点实验室 Culture medium, culture method and application of pluripotent stem cells
EP3835403A1 (en) 2019-12-11 2021-06-16 Sartorius Stedim Biotech GmbH Automated medium exchange strategy for suspension cells
KR102291265B1 (en) * 2020-03-19 2021-08-18 연세대학교 산학협력단 Cardiac organoids, method for preparing the same and method for evaluating drug toxicity using the same
WO2021197334A1 (en) * 2020-03-31 2021-10-07 浙江养生堂天然药物研究所有限公司 Pharmaceutical combination and use thereof
EP3945133A1 (en) 2020-07-29 2022-02-02 Georg-August-Universität Göttingen Mass production of human pluripotent stem cell derived cardiac stromal cell
EP3988138B1 (en) 2020-10-22 2024-01-17 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Multilayer engineered heart muscle
EP4281767A1 (en) 2021-01-21 2023-11-29 Sartorius Stedim Biotech GmbH Application of permittivity measurement probes in an suspension culture aggregate comprising cell aggregates
CN117043313A (en) 2021-01-21 2023-11-10 赛多利斯斯泰帝生物技术有限公司 Method for changing culture medium of culture using rotary filter
CN113249310B (en) * 2021-05-17 2022-10-11 湖北大学 Method for induced differentiation of expansion pluripotent stem cells into myocardial cells and application
CN113337459B (en) * 2021-06-02 2022-09-06 呈诺再生医学科技(珠海横琴新区)有限公司 Method for improving differentiation efficiency of pluripotent stem cells
US12076437B2 (en) 2021-07-12 2024-09-03 Brown University Proangiogenic protein cocktails delivered in custom biomaterials to revascularize ischemic tissue
US20230147883A1 (en) * 2021-11-28 2023-05-11 Fatemeh Etezadi Method for prodcing cardiomyocytes from induced pluripotent stem cells in an integrated process
WO2024008773A1 (en) * 2022-07-05 2024-01-11 Repairon Gmbh Differentiation of ipscs in bioreactors
EP4386384A1 (en) 2022-12-15 2024-06-19 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Potency assay for pharmaceutical products

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014209A1 (en) * 2002-01-23 2004-01-22 Lassar Andrew B. Compositions and methods for modulating cell differentiation
EP1783206A1 (en) * 2005-11-08 2007-05-09 Universitätsklinikum Hamburg-Eppendorf Multiring engineered heart tissue construct
JP2008307007A (en) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth
US20100278787A1 (en) * 2007-07-18 2010-11-04 Cellartis Ab Cardiomyocyte-like cell clusters derived from hbs cells
EP2100954A1 (en) * 2008-03-10 2009-09-16 Assistance Publique - Hopitaux de Paris Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications
CN102165058B (en) * 2008-07-25 2015-07-01 佐治亚大学研究基金会 Compositions for mesoderm derived ISLl1+ multipotent cells (IMPs), epicardial progenitor cells (EPCs) and multipotent CXCR4+CD56+ cells (C56Cs) and methods of use
US8765117B2 (en) * 2009-06-10 2014-07-01 The General Hospital Corporation Generation of vascularized human heart tissue and uses thereof
CN101935635A (en) * 2010-07-30 2011-01-05 中国人民解放军第二军医大学 In vitro amplification method of human marrow pluripotent stem cells and method for directionally differentiating same into dopaminergic neuron
US9023340B2 (en) * 2011-07-02 2015-05-05 Chemregen, Inc. Wnt inhibitors for human stem cell differentiation
CN103987854A (en) 2011-07-21 2014-08-13 小利兰·斯坦福大学托管委员会 Cardiomyocytes from induced pluripotent stem cells from patients and methods of use
WO2013056072A1 (en) * 2011-10-13 2013-04-18 Wisconsin Alumni Research Foundation Generation of cardiomyocytes from human pluripotent stem cells
WO2013063305A2 (en) 2011-10-25 2013-05-02 Mount Sinai School Of Medicine Directed cardiomyocyte differentiation of stem cells
WO2013111875A1 (en) * 2012-01-27 2013-08-01 国立大学法人京都大学 Method for inducing differentiation of pluripotent stem cell into cardiac muscle
DK2840132T3 (en) * 2013-08-22 2017-02-20 Georg-August-Universität Göttingen Stiftung Öffenlichen Rechts Universitätsmedizin Method of Manufacturing Constructed Heart Muscle (EHM)

Also Published As

Publication number Publication date
JP7548538B2 (en) 2024-09-10
EP3047019A1 (en) 2016-07-27
AU2014323098A1 (en) 2016-05-05
CN105849253A (en) 2016-08-10
CN105849253B (en) 2020-10-09
CA2924816C (en) 2023-09-05
JP2020115866A (en) 2020-08-06
WO2015040142A1 (en) 2015-03-26
US20190300858A1 (en) 2019-10-03
DK3047019T3 (en) 2019-08-26
JP2016536975A (en) 2016-12-01
SG10201910753RA (en) 2020-01-30
AU2014323098B2 (en) 2020-09-17
EP3575393A1 (en) 2019-12-04
US20160215264A1 (en) 2016-07-28
CN112175900A (en) 2021-01-05
CA2924816A1 (en) 2015-03-26
EP3047019B1 (en) 2019-07-03
US10329532B2 (en) 2019-06-25
JP6681825B2 (en) 2020-04-15
SG10201802167TA (en) 2018-04-27
US20190010460A1 (en) 2019-01-10
ES2741806T3 (en) 2020-02-12

Similar Documents

Publication Publication Date Title
SG10201910753RA (en) A method to direct differentiation of pluripotent stem cells into functional heart muscle
EP2808383A4 (en) Method for inducing differentiation of pluripotent stem cell into cardiac muscle
EP2861612A4 (en) Methods of preparing pluripotent stem cells
EP3234108A4 (en) Differentiation of pluripotent stem cells to form renal organoids
HK1217211A1 (en) Methods modulating immunoregulatory effect of stem cells
SG10201802390XA (en) Methods of differentiating stem cells into one or more cell lineages
IL236672B (en) System and methods for preparation of adipose-derived stem cells
HK1208492A1 (en) Highly efficient method for establishing artificial pluripotent stem cell
EP2826855A4 (en) Method for producing cardiac and vascular cell mixture from artificial pluripotent stem cells
EP2968549A4 (en) Methods of cell culture
PL2741535T3 (en) A method to guide the placement of new small cells
EP2971040A4 (en) Methods of cell culture
EP2794860A4 (en) Method for inducing differentiation of human pluripotent stem cells into intermediate mesoderm cells
EP2971014A4 (en) Methods of cell culture
GB201223210D0 (en) Method of attaching a dental component to a dental implant
HK1222200A1 (en) Method for preparing pluripotent stem cells
EP2900808A4 (en) Methods of differentiating stem cells into chondrocytes
HK1220487A1 (en) Method for inducing pluripotent stem cells and pluripotent stem cells prepared by said method
SG11201503167XA (en) Method of efficiently establishing induced pluripotent stem cells
EP2912166A4 (en) Methods of producing pluripotent stem cells from chondrocytes
GB2523696B (en) Methods of differentiating stem cells to pancreatic progenitor cells by modulating miR-124
EP2913396A4 (en) Method of manufacturing differentiated pluripotent stem cell
EP2949746A4 (en) Method of subculturing pluripotent stem cells
HK1208249A1 (en) Method of extracting neural stem cells using nanoparticles
EP3050961A4 (en) Method for improving efficiency of inducing pluripotent stem cell